Connect with Us
LP Login
Français
Businesses
Overview
Private Equity
Credit
Healthcare Royalties
Venture
SPAC
Real Estate
Private Wealth
About Us
Who We Are
Firm History
Board of Directors
People
Team
Advisors
Portfolio
Responsibility
Insights
News and Events
Businesses
Overview
Private Equity
Credit
Healthcare Royalties
Venture
SPAC
Real Estate
Private Wealth
About Us
Who We Are
Firm History
Board of Directors
People
Team
Advisors
Portfolio
Responsibility
Insights
News and Events
Businesses
Overview
Private Equity
Credit
Healthcare Royalties
Venture
SPAC
Real Estate
Private Wealth
About Us
Who We Are
Firm History
Board of Directors
People
Team
Advisors
Portfolio
Responsibility
Insights
News and Events
Businesses
Overview
Private Equity
Credit
Healthcare Royalties
Venture
SPAC
Real Estate
Private Wealth
About Us
Who We Are
Firm History
Board of Directors
People
Team
Advisors
Portfolio
Responsibility
Insights
News and Events
Connect With Us
LP Login
Communiquez avec nous
Connexion
Français
Back
Sagard Signs $50 Million Royalty Deal for Athenex Cancer Drug | Wall Street Journal
August 06, 2020